<DOC>
	<DOC>NCT00466609</DOC>
	<brief_summary>This will be a controlled, randomized, double-blind and double-dummy study on the treatment augmentation strategy for obsessive compulsive disorder patients non-respondent to first line pharmacological treatment. The investigators will compare: fluoxetine maintenance at maximum dosage for additional 12 weeks; the association of fluoxetine with quetiapine; and the association of fluoxetine with clomipramine.</brief_summary>
	<brief_title>Using Drug Augmentation to Treat Obsessive Compulsive Disorder Patients Who Did Not Respond to Previous Treatment</brief_title>
	<detailed_description>Arm 1: SSRI (Fluoxetine 40mg* once a day) + Clomipramine 75mg* once a day. Arm 2: SSRI (Fluoxetine 40mg* once a day) + Quetiapine 200mg* once a day. Arm 3: SSRI (Fluoxetine 80mg* once a day) + Placebo once a day. *or maximum tolerated dose We hypothesize that quetiapine and clomipramine will be effective augmentation strategies for resistant OCD patients in comparison to placebo.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Clomipramine</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>1. OCD diagnosis 2. YBOCS score ≥ 16 (for patients with both obsessions and compulsions) or ≥ 10 (for patients with only obsessions or compulsions) 3. Previously signed informed consent to participate in this clinical trial 1. Patients with clinical or neurological diseases that may be worsen by the medications included in treatment protocol 2. Current substance dependence or abuse 3. Current psychotic symptoms 4. Current suicide risk 5. Current pregnancy or intention to get pregnant before the end of the treatment protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2010</verification_date>
	<keyword>clomipramine</keyword>
	<keyword>quetiapine</keyword>
	<keyword>fluoxetine</keyword>
	<keyword>placebo</keyword>
	<keyword>augmentation</keyword>
	<keyword>obsessive compulsive disorder</keyword>
</DOC>